Table 5.
Calculated positive and negative predictive values for FilmArray RP and DFCI/BWH clinically indicated testing
| Sample typea | Test | Calculated positive predictive value (CI)b | Calculated negative predictive value (CI)b |
|---|---|---|---|
| Allc | DFCI/BWH | 1.00 (0.79, 1.00) | 0.84 (0.74, 0.91) |
| FilmArray RP | 0.86 (0.68, 0.96) | 1.00 (0.95, 1.00) | |
| BALc | DFCI/BWH | 1.00 (0.37, 1.00) | 0.90 (0.78, 0.97) |
| FilmArray RP | 0.89 (0.52, 1.00) | 1.00 (0.93, 1.00) | |
| NPA | DFCI/BWH | 1.00 (0.74, 1.00) | 0.71 (0.49, 0.87) |
| FilmArray RP | 0.85 (0.62, 0.97) | 1.00 (0.81, 1.00) |
BAL, bronchoalveolar lavage; NPA, nasopharyngeal aspirate.
The estimated positive and negative predictive values did not change much when the second sample obtained from the three patients who underwent testing twice was excluded. CI, confidence interval.
These estimates excluded the three samples in which parainfluenza virus 2 and parainfluenza virus 3 were detected by clinical testing but not by FilmArray RP assay, since verification testing did not test for either of these pathogens.